Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population-based retrospective cohort study.

Amber Afzal Brian F GageLuo SuhongMartin W SchoenKevin KorenblatKristen M Sanfilippo

Published in: Journal of thrombosis and haemostasis : JTH (2022)

The relationship between INR and risk of hemorrhage in CLD patients is different from that in warfarin users. Caution should be exercised extrapolating data from warfarin users to make clinical decisions in CLD patients.

Keyphrases

end stage renal disease
newly diagnosed
atrial fibrillation
chronic kidney disease
venous thromboembolism
prognostic factors
stem cells
direct oral anticoagulants
machine learning
cell therapy